740
Views
11
CrossRef citations to date
0
Altmetric
Research Article

Cytotoxic effects and specific gene expression alterations induced by I-125-labeled triplex-forming oligonucleotides

&
Pages 972-979 | Received 01 May 2012, Accepted 06 Jun 2012, Published online: 02 Aug 2012

References

  • Alberts B. 2010.Cell biology: The endless frontier. Molecular Biology of the Cell 21:3785–3785.
  • Forsha SJ, Panyutin IV, Neumann RD, Panyutin IG. 2010. Intracellular traffic of oligodeoxynucleotides in and out of the nucleus: Effect of exportins and DNA structure. Oligonucleotides 20:277–284.
  • Frank-Kamenetskii MD, Mirkin SM. 1995. Triplex DNA structures. Annual Review of Biochemistry 64:65–95.
  • Goni JR, de la Cruz X, Orozco M. 2004. Triplex-forming oligonucleotide target sequences in the human genome. Nucleic Acids Research 32:354–60.
  • Huppert JL, Balasubramanian S. 2007. G-quadruplexes in promoters throughout the human genome. Nucleic Acids Research 35:406–413.
  • Kassis AI, Harapanhalli RS, Adelstein SJ. 1996. Comparison of strand breaks in plasmid DNA following positional changes of Auger- electron-emitting iodine-125. Journal of Nuclear Medicine 37:397–397.
  • Kriehuber R, Riedling M, Simkó M, Weiss DG. 2004. Cytotoxicity, genotoxicity and intracellular distribution of the Auger electron emitter (65)Zn in two human cell lines. Radiation and Environmental Biophysics 43:15–22.
  • Kumar P, Yadav VK, Baral A, Kumar P, Saha D, Chowdhury S. 2011. Zinc-finger transcription factors are associated with guanine quadruplex motifs in human, chimpanzee, mouse and rat promoters genome-wide. Nucleic Acids Research 39:8005–8016.
  • Kuznetsova S, Ait-Si-Ali S, Nagibneva I, Troalen F, Le Villain JP, Harel-Bellan A, Svinarchuk F. 1999. Gene activation by triplex-forming oligonucleotide coupled to the activating domain of protein VP16. Nucleic Acids Research 27:3995–4000.
  • Lobachevsky PN, Martin RF. 1996. DNA strand breakage by 125I-decay in a synthetic oligodeoxynucleotide-2. Quantitative analysis of fragment distribution. Acta Oncol 35:809–815.
  • Longe HO, Romesser PB, Rankin AM, Faller DV, Eller MS, Gilchrest BA, DenisGV. 2009. Telomere homolog oligonucleotides induce apoptosis in malignant but not in normal lymphoid cells: Mechanism and therapeutic potential. International Journal of Cancer 124:473–482.
  • Onyshchenko MI, Gaynutdinov TI, Englund EA, Appella DH, Neumann RD, Panyutin IG. 2011. Quadruplex formation is necessary for stable PNA invasion into duplex DNA of BCL2 promoter region. Nucleic Acids Research 39:7114–7123.
  • Panyutin IG, Neumann RD. 1994. Sequence-specific DNA double-strand breaks induced by triplex forming 125I labeled oligonucleotides. Nucleic Acids Research 22:4979–4982.
  • Panyutin IG, Neumann RD. 1996. Sequence-specific DNA breaks produced by triplex-directed decay of iodine-125. Acta Oncologica 35:817–823.
  • Panyutin IG, Sedelnikova OA, Karamychev VN, Neumann RD. 2003. Antigene radiotherapy: Targeted radiodamage with 125I-labeled triplex-forming oligonucleotides. Annals of the New York Academy of Sciences 1002:134–140.
  • Pomplun E, Booz J, Dydejczy kA, Feinendegen LE. 1987. A microdosimetric interpretation of the radiobiological effectiveness of 125I and the problem of quality factor. Radiation and Environmental Biophysics 26:181–188.
  • Praseuth D, Perrouault L, Doan TL, Chassignol M, Thuong N, Helene C. 1988. Sequence-specific binding and photocrosslinking of alpha-oligodeoxynucleotides and beta-oligodeoxynucleotides to the major groove of DNA via triple-helix formation. Proceedings of the National Academy of Sciences of the USA 85:1349–1353.
  • Schultz LB, Chehab NH, Malikzay A, Halazonetis TD. 2000. p53 Binding protein 1 (53BP1) is an early participant in the cellular response to DNA double-strand breaks. Journal of Cell Biology 151:1381–1390.
  • Sedelnikova OA, Panyutin IG, Thierry AR, Neumann RD. 1998. Radiotoxicity of Iodine-125-labeled oligodeoxyribonucleotides in mammalian cells. Journal of Nuclear Medicine 39:1412–1418.
  • Sedelnikova OA, Luu AN, Karamychev VN, Panyutin IG, Neumann RD. 2001. Development of DNA-based radiopharmaceuticals carrying Auger-electron emitters for antigene radiotherapy. International Journal of Radiation Oncology*Biology*Physics 49:391–396.
  • Sedelnikova OA, Panyutin IV, Neumann RD, Bonner WM, Panyutin IG. 2004. Assessment of DNA damage produced by 125I-triplex- forming oligonucleotides in cells. International Journal of Radiation Biology 80:927–931.
  • Sedelnikova OA, Panyutin IG, Luu AN, Reed MW, Licht T, Gottesman MM, Neumann RD. 2000. Targeting the human mdr1 gene by 125I-labeled triplex-forming oligonucleotides. Antisense and Nucleic Acid Drug Development 10:443–452.
  • Stout JT, Caskey CT. 1985. HPRT: Gene structure, expression, and mutation. Annual Review of Genetic 19:127–148.
  • Tilgen W, Boukamp P, Breitkreutz D, Dzarlieva RT, Engstner M, Haag D, Fusenig NE. 1983. Preservation of morphological, functional, and karyotypic traits during long-term culture and in vivo passage of two human skin squamous cell carcinomas. Cancer Research 43:5995–6011.
  • Todd AK, Johnston M, Neidle S. 2005. Highly prevalent putative quadruplex sequence motifs in human DNA. Nucleic Acids Research 33:2901–2907.
  • Vekhoff P, Ceccaldi A, Polverari D, Pylouster J, Pisano C, Arimondo P. 2008. Triplex formation on DNA targets: How to choose the oligonucleotide. Biochemistry 47:12277–12289.
  • Verma A, Yadav VK, Basundra R, Kumar A, Chowdhury S. 2009. Evidence of genome-wide G4 DNA-mediated gene expression in human cancer cells. Nucleic Acids Research 37:4194–4204.